clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Carnegie Mellon Nets $80M+ For Cell-Based Bioelectronics to Monitor and Treat…
News & Features
Anti-Inflammatory Marker Holds Promise for Cardiovascular Vaccine
Molecular Dx
Veracyte’s RNA Genetic Test Predicts Black Men’s Aggressive Prostate Cancer
News & Features
New Drug Candidate Works to Inhibit Both Tau Protein “Hotspots” in…
News & Features
Early-Onset Colorectal Cancer Shows Sex-Specific Features
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Outpatient CAR T Therapy Is Safe and Effective in Community Setting
Cell immunotherapy
News & Features
Outpatient CAR T Therapy Is Safe and Effective in Community Setting
October 1, 2024
0
Molecular Dx
AACR Details Progress against Cancer in 2024 Report
September 25, 2024
0
News & Features
New Research Identifies METRNL Protein as Key Obstacle to Cancer-Fighting T Cells
August 7, 2024
0
News & Features
First Engineered T Cell Therapy for Solid Tumors Approved by the FDA
August 5, 2024
0
News & Features
New Cellular Immunotherapy Shows Promise against Solid Tumors in Phase II Trial
July 12, 2024
0
News & Features
Altering CAR Proteins Improves T Cells’ Ability to Attack Solid Tumors
May 8, 2024
0
News & Features
New Immune Mechanism That Interferes with Checkpoint Inhibitors Revealed
May 8, 2024
0
News & Features
UCSF Launches Clinical Trial on New CAR T Therapy for Glioblastoma
April 24, 2024
0
News & Features
Obsidian Raises $160M+ to Advance Novel Solid Tumor Immunotherapy
April 5, 2024
0
News & Features
Next-Generation T Cell Therapy Shows Promise For Solid Tumors
Laura Cowen
April 3, 2024
0
1
2
3
...
5
Page 1 of 5
Related Content
New Drug Candidate Works to Inhibit Both Tau Protein “Hotspots” in Alzheimer’s Disease
New Research Identifies METRNL Protein as Key Obstacle to Cancer-Fighting T Cells
First Engineered T Cell Therapy for Solid Tumors Approved by the FDA
CAR-T Targeting CD22 Delivers Positive Early Results in Lymphoma
Inside Precision Medicine